aspirin has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boucheix, C; Carroll, RC; Worthington, RE | 1 |
| Maridonneau-Parini, I; Tauber, AI; Tringale, SM | 1 |
| Hidaka, H; Nishikawa, M; Shirakawa, S | 1 |
| Crockett, J; Levine, RA; Nandi, J | 1 |
| Mitchell, MD; Pollard, JK | 1 |
| Chang, B; Chang, WC; Jen, CJ; Lin, MT; Shi, GY; Tasi, CF; Wang, SJ; Wing, LY; Wu, HL | 1 |
| Aseichev, AV; Azizova, OA | 1 |
7 other study(ies) available for aspirin and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
| Article | Year |
|---|---|
Stimulus-response coupling in human platelets activated by monoclonal antibodies to the CD9 antigen, a 24 kDa surface-membrane glycoprotein.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Diphosphate; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Aspirin; Blood Platelets; Calcium; Collagen; Humans; Hydrogen-Ion Concentration; Immunoglobulin Fab Fragments; Isoquinolines; Membrane Glycoproteins; Phosphoproteins; Piperazines; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Kinase C; Serotonin; Signal Transduction; Tetraspanin 29; Thromboxane A2 | 1990 |
Identification of distinct activation pathways of the human neutrophil NADPH-oxidase.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Arachidonic Acid; Arachidonic Acids; Aspirin; Calcium; Enzyme Activation; Humans; Indomethacin; Isoquinolines; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Phospholipases A; Phospholipases A2; Phospholipids; Piperazines; Pyrazoles; Quinacrine; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1986 |
Possible involvement of direct stimulation of protein kinase C by unsaturated fatty acids in platelet activation.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Arachidonic Acids; Aspirin; Blood Platelets; Enzyme Activation; Fatty Acids, Unsaturated; Humans; Isoquinolines; Phosphorylation; Piperazines; Platelet Aggregation; Protein Kinase C; Staurosporine; Time Factors | 1988 |
A possible role of protein kinase C in augmenting H+ secretion by nonsteroidal anti-inflammatory drugs.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bucladesine; Histamine; Ibuprofen; Isoquinolines; Male; Piperazines; Protein Kinase C; Protons; Rabbits; Rana catesbeiana; Tetradecanoylphorbol Acetate | 1994 |
Tumor necrosis factor alpha stimulates amnion prostaglandin biosynthesis primarily via an action on fatty acid cyclooxygenase.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Amnion; Arachidonic Acid; Aspirin; Cells, Cultured; Cycloheximide; Dactinomycin; Dinoprostone; Female; Humans; Isoquinolines; Piperazines; Pregnancy; Prostaglandin-Endoperoxide Synthases; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1993 |
Regulation of plasminogen activator inhibitor activity by plasmin in endothelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Aspirin; Cells, Cultured; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Fibrinolysin; Fibrinolysis; Gene Expression Regulation; GTP-Binding Proteins; Humans; Indomethacin; Isoquinolines; Lipoxygenase Inhibitors; Masoprocol; Pertussis Toxin; Phospholipases A; Phospholipases A2; Piperazines; Plasminogen Activator Inhibitor 1; Protein Kinase C; Quinacrine; Staurosporine; Tissue Plasminogen Activator; Umbilical Veins; Virulence Factors, Bordetella | 1996 |
Mechanism of activation of ADP-induced platelet aggregation under the influence of oxidatively modified fibrinogen.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Diphosphate; Aspirin; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Estrenes; Fibrinogen; Genistein; Humans; In Vitro Techniques; Oxidation-Reduction; Platelet Aggregation; Protein Kinase C; Protein-Tyrosine Kinases; Pyrrolidinones; Type C Phospholipases; Ultraviolet Rays | 2004 |